Prof. Aphrodite Kapurniotu and members of her researchteam (IMAGE)

Technical University of Munich (TUM)

Prof. Aphrodite Kapurniotu and members of her researchteam

Caption

Researchers at the Technical University of Munich (TUM) have developed synthetic peptides that could potentially serve as the foundation for future medications to treat Alzheimer’s, Parkinson’s, and type 2 diabetes. In the picture: Aphrodite Kapurniotu in the laboratory with some of the researchers involved (from left to right: Beatrice Dalla Volta, Aphrodite Kapurniotu, Beatrice Marcon, and Simon Hornung)

Credit

Astrid Eckert / TUM

Usage Restrictions

Verwendung frei für die Berichterstattung über die TUM bei Nennung des Copyrights / Free for use in reporting on TUM, with the copyright noted

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.